Format
Sort by

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 88

1.

Comparison of radiofrequency ablation and resection for hepatic metastasis from colorectal cancer.

Lee KH, Kim HO, Yoo CH, Son BH, Park YL, Cho YK, Kim H, Han WK.

Korean J Gastroenterol. 2012 Mar;59(3):218-23.

2.

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).

Ruers T, Punt C, Van Coevorden F, Pierie JP, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M, Van Cutsem E, Lutz MP, Nordlinger B; EORTC Gastro-Intestinal Tract Cancer Group, Arbeitsgruppe Lebermetastasen und—tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO) and the National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG).

Ann Oncol. 2012 Oct;23(10):2619-26. Epub 2012 Mar 19.

3.

Minimally invasive evaluation and treatment of colorectal liver metastases.

Gueorguiev AL, Mackey R, Kowdley GC, Esquivel J, Cunningham SC.

Int J Surg Oncol. 2011;2011:686030. doi: 10.1155/2011/686030. Epub 2011 Jul 7.

4.

Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience.

Nace GW, Steel JL, Amesur N, Zajko A, Nastasi BE, Joyce J, Sheetz M, Gamblin TC.

Int J Surg Oncol. 2011;2011:571261. doi: 10.1155/2011/571261. Epub 2011 Mar 20.

5.

Yttrium-90 radioembolization as salvage therapy for colorectal cancer with liver metastases.

Martin LK, Cucci A, Wei L, Rose J, Blazer M, Schmidt C, Khabiri H, Bloomston M, Bekaii-Saab T.

Clin Colorectal Cancer. 2012 Sep;11(3):195-9. doi: 10.1016/j.clcc.2011.12.002. Epub 2012 Jan 24.

6.

Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.

Aliberti C, Fiorentini G, Muzzio PC, Pomerri F, Tilli M, Dallara S, Benea G.

Anticancer Res. 2011 Dec;31(12):4581-7.

PMID:
22199334
7.

Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis.

Wu YZ, Li B, Wang T, Wang SJ, Zhou YM.

World J Gastroenterol. 2011 Sep 28;17(36):4143-8. doi: 10.3748/wjg.v17.i36.4143.

8.

Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors.

Kucuk ON, Soydal C, Lacin S, Ozkan E, Bilgic S.

World J Surg Oncol. 2011 Aug 6;9:86. doi: 10.1186/1477-7819-9-86. Erratum in: World J Surg Oncol. 2011;9:120.

9.

Liver-directed therapies in colorectal cancer.

Alsina J, Choti MA.

Semin Oncol. 2011 Aug;38(4):561-7. doi: 10.1053/j.seminoncol.2011.05.010. Review.

PMID:
21810515
10.

Modern insights into hepatic arterial infusion for liver metastases from colorectal cancer.

Bouchahda M, Lévi F, Adam R, Rougier P.

Eur J Cancer. 2011 Dec;47(18):2681-90. doi: 10.1016/j.ejca.2011.06.037. Epub 2011 Jul 21. Review.

PMID:
21783358
11.

Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?

Meza-Junco J, Montano-Loza AJ, Liu DM, Sawyer MB, Bain VG, Ma M, Owen R.

Cancer Treat Rev. 2012 Feb;38(1):54-62. doi: 10.1016/j.ctrv.2011.05.002. Epub 2011 Jul 2. Review.

PMID:
21726960
12.

Candidacy for sorafenib in HCC patients: is there a slippery slope beyond a SHARP edge?

Burak KW.

Oncology (Williston Park). 2011 Mar;25(3):296, 298, 300. Review. No abstract available.

PMID:
21548474
13.

Chemotherapy plus percutaneous radiofrequency ablation in patients with inoperable colorectal liver metastases.

Sgouros J, Cast J, Garadi KK, Belechri M, Breen DJ, Monson JR, Maraveyas A.

World J Gastrointest Oncol. 2011 Apr 15;3(4):60-6. doi: 10.4251/wjgo.v3.i4.60.

14.

Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer.

Kosmider S, Tan TH, Yip D, Dowling R, Lichtenstein M, Gibbs P.

J Vasc Interv Radiol. 2011 Jun;22(6):780-6. doi: 10.1016/j.jvir.2011.02.023. Epub 2011 Apr 22.

PMID:
21515072
15.

Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship?

Vautravers-Dewas C, Dewas S, Bonodeau F, Adenis A, Lacornerie T, Penel N, Lartigau E, Mirabel X.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e39-47. doi: 10.1016/j.ijrobp.2010.12.047. Epub 2011 Mar 4.

PMID:
21377292
16.

A review of the treatment of chronic hepatitis C virus infection in cirrhosis.

Vezali E, Aghemo A, Colombo M.

Clin Ther. 2010 Dec;32(13):2117-38. doi: 10.1016/S0149-2918(11)00022-1. Review.

PMID:
21316532
17.

Hepatocellular carcinoma: current management and perspectives for the future.

Rahbari NN, Mehrabi A, Mollberg NM, Müller SA, Koch M, Büchler MW, Weitz J.

Ann Surg. 2011 Mar;253(3):453-69. doi: 10.1097/SLA.0b013e31820d944f. Review.

PMID:
21263310
18.

Hepatic arterial infusion of 5-fluorouracil for patients with liver metastases from colorectal cancer refractory to standard systemic chemotherapy: a multicenter, retrospective analysis.

Nishiofuku H, Tanaka T, Aramaki T, Boku N, Inaba Y, Sato Y, Matsuoka M, Otsuji T, Arai Y, Kichikawa K.

Clin Colorectal Cancer. 2010 Dec;9(5):305-10. doi: 10.3816/CCC.2010.n.044. Erratum in: Clin Colorectal Cancer. 2011 Mar 1;10(1):7.

PMID:
21208845
19.

Review of the processes for FDA oversight of drugs, medical devices, and combination products.

Sweet BV, Schwemm AK, Parsons DM.

J Manag Care Pharm. 2011 Jan-Feb;17(1):40-50. Review. No abstract available.

20.

Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases.

Chua TC, Bester L, Saxena A, Morris DL.

J Cancer Res Clin Oncol. 2011 May;137(5):865-73. doi: 10.1007/s00432-010-0948-y. Epub 2010 Sep 22.

PMID:
20859640
Items per page

Supplemental Content

Write to the Help Desk